Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Net Income (2016 - 2025)

Historic Net Income for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $8.8 million.

  • Fortress Biotech's Net Income rose 13302.9% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 3667.35%. This contributed to the annual value of -$120.9 million for FY2024, which is 2160.11% up from last year.
  • Latest data reveals that Fortress Biotech reported Net Income of $8.8 million as of Q3 2025, which was up 13302.9% from -$35.9 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Net Income ranged from a high of $8.8 million in Q3 2025 and a low of -$62.4 million during Q4 2021
  • Its 5-year average for Net Income is -$37.1 million, with a median of -$35.9 million in 2025.
  • Per our database at Business Quant, Fortress Biotech's Net Income plummeted by 15968.02% in 2021 and then skyrocketed by 13302.9% in 2025.
  • Fortress Biotech's Net Income (Quarter) stood at -$62.4 million in 2021, then increased by 7.88% to -$57.4 million in 2022, then skyrocketed by 49.54% to -$29.0 million in 2023, then grew by 9.21% to -$26.3 million in 2024, then soared by 133.54% to $8.8 million in 2025.
  • Its Net Income was $8.8 million in Q3 2025, compared to -$35.9 million in Q2 2025 and -$21.8 million in Q1 2025.